comparemela.com

MIL-OSI: Jeito Capital co-leads $156 million oversubscribed Series B financing in Quell Therapeutics

MIL-OSI: Jeito Capital co-leads $156 million oversubscribed Series B financing in Quell Therapeutics

foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.

Related Keywords

Boston ,Massachusetts ,United States ,Paris ,France General ,France ,United Kingdom ,London ,City Of ,British ,Iain Mcgill ,Rachel Mears ,Partnerat Jeito ,Hynd Boumehdi ,Marion Bougeard ,Linkedin ,Sv Health Investors ,Jazz Pharmaceuticals ,Tekla Capital Management ,Fidelity Management Research Company ,Novartis ,Consilium Strategic Communications ,Jeito Capital ,Quell Therapeutics ,Ridgeback Capital Investments ,Fidelity Management ,Research Company ,British Patient Capital ,Future Fund ,Janus Henderson Investors ,Monashee Investment Management ,Chief Executive Officer Iain Mcgill ,Dominik Hartl ,Chief Medical Officer ,Tracey Lodie ,Chief Scientific ,United Kingdom With ,Chief Executive Officer ,Jane Elliott ,Melissa Gardiner ,Davide Salvi ,

comparemela.com © 2020. All Rights Reserved.